Global Follicular Lymphoma Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4887721
- 80 Pages
- March 2022
- Automotive and Transportation
This report presents a comprehensive overview, market shares, and growth opportunities of Follicular Lymphoma Drugs market by product type, application, key players and key regions and countries.
Segmentation by product type:
Chemotherapy Drug
Monoclonal Antibody
Kinase Inhibitor
CAR T-cell Therapy
Others
Segmentation by Application:
< 55
55-64
65+
This report also splits the market by region:
United States
China
Europe
Other regions:
Japan
South Korea
Southeast Asia
Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
Genentech (Roche)
Bristol-Myers Squibb
Gilead Sciences
TG Therapeutics
Bayer
Secura Bio
Epizyme
Jazz Pharmaceuticals
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Follicular Lymphoma Drugs Market Size 2022-2028
2.1.2 Follicular Lymphoma Drugs Market Size CAGR by Region
2.2 Follicular Lymphoma Drugs Segment by Type
2.2.1 Chemotherapy Drug
2.2.2 Monoclonal Antibody
2.2.3 Kinase Inhibitor
2.2.4 CAR T-cell Therapy
2.2.5 Others
2.3 Follicular Lymphoma Drugs Market Size by Type
2.3.1 Global Follicular Lymphoma Drugs Market Size Market Share by Type (2022-2028)
2.3.2 Global Follicular Lymphoma Drugs Market Size Growth Rate by Type (2022-2028)
2.4 Follicular Lymphoma Drugs Segment by Application
2.4.1 < 55
2.4.2 55-64
2.4.3 65+
2.5 Follicular Lymphoma Drugs Market Size by Application
2.5.1 Global Follicular Lymphoma Drugs Market Size Market Share by Application (2022-2028)
2.5.2 Global Follicular Lymphoma Drugs Market Size Growth Rate by Application (2022-2028)
3 Follicular Lymphoma Drugs Key Players
3.1 Date of Key Players Enter into Follicular Lymphoma Drugs
3.2 Key Players Follicular Lymphoma Drugs Product Offered
3.3 Key Players Follicular Lymphoma Drugs Funding/Investment Analysis
3.4 Funding/Investment
3.4.1 Funding/Investment by Regions
3.4.2 Funding/Investment by End-Industry
3.5 Key Players Follicular Lymphoma Drugs Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions
4 Follicular Lymphoma Drugs by Regions
4.1 Follicular Lymphoma Drugs Market Size by Regions (2022-2028)
4.2 United States Follicular Lymphoma Drugs Market Size Growth (2022-2028)
4.3 China Follicular Lymphoma Drugs Market Size Growth (2022-2028)
4.4 Europe Follicular Lymphoma Drugs Market Size Growth (2022-2028)
4.5 Rest of World Follicular Lymphoma Drugs Market Size Growth (2022-2028)
5 United States
5.1 United States Follicular Lymphoma Drugs Market Size by Type (2022-2028)
5.2 United States Follicular Lymphoma Drugs Market Size by Application (2022-2028)
6 China
6.1 China Follicular Lymphoma Drugs Market Size by Type (2022-2028)
6.2 China Follicular Lymphoma Drugs Market Size by Application (2022-2028)
7 Europe
7.1 Europe Follicular Lymphoma Drugs Market Size by Type (2022-2028)
7.2 Europe Follicular Lymphoma Drugs Market Size by Application (2022-2028)
8 Rest of World
8.1 Rest of World Follicular Lymphoma Drugs Market Size by Type (2022-2028)
8.2 Rest of World Follicular Lymphoma Drugs Market Size by Application (2022-2028)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Key Investors in Follicular Lymphoma Drugs
10.1 Company A
10.1.1 Company A Company Details
10.1.2 Company Description
10.1.3 Companies Invested by Company A
10.1.4 Company A Key Development and Market Layout
10.2 Company B
10.2.1 Company B Company Details
10.2.2 Company Description
10.2.3 Companies Invested by Company B
10.2.4 Company B Key Development and Market Layout
10.3 Company C
10.3.1 Company C Company Details
10.3.2 Company Description
10.3.3 Companies Invested by Company C
10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……
11 Key Players Analysis
11.1 Genentech (Roche)
11.1.1 Genentech (Roche) Company Details
11.1.2 Genentech (Roche) Follicular Lymphoma Drugs Product Offered
11.1.3 Genentech (Roche) Follicular Lymphoma Drugs Market Size (2022 VS 2027)
11.1.4 Genentech (Roche) Main Business Overview
11.1.5 Genentech (Roche) News
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Details
11.2.2 Bristol-Myers Squibb Follicular Lymphoma Drugs Product Offered
11.2.3 Bristol-Myers Squibb Follicular Lymphoma Drugs Market Size (2022 VS 2027)
11.2.4 Bristol-Myers Squibb Main Business Overview
11.2.5 Bristol-Myers Squibb News
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Follicular Lymphoma Drugs Product Offered
11.3.3 Gilead Sciences Follicular Lymphoma Drugs Market Size (2022 VS 2027)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences News
11.4 TG Therapeutics
11.4.1 TG Therapeutics Company Details
11.4.2 TG Therapeutics Follicular Lymphoma Drugs Product Offered
11.4.3 TG Therapeutics Follicular Lymphoma Drugs Market Size (2022 VS 2027)
11.4.4 TG Therapeutics Main Business Overview
11.4.5 TG Therapeutics News
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Follicular Lymphoma Drugs Product Offered
11.5.3 Bayer Follicular Lymphoma Drugs Market Size (2022 VS 2027)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer News
11.6 Secura Bio
11.6.1 Secura Bio Company Details
11.6.2 Secura Bio Follicular Lymphoma Drugs Product Offered
11.6.3 Secura Bio Follicular Lymphoma Drugs Market Size (2022 VS 2027)
11.6.4 Secura Bio Main Business Overview
11.6.5 Secura Bio News
11.7 Epizyme
11.7.1 Epizyme Company Details
11.7.2 Epizyme Follicular Lymphoma Drugs Product Offered
11.7.3 Epizyme Follicular Lymphoma Drugs Market Size (2022 VS 2027)
11.7.4 Epizyme Main Business Overview
11.7.5 Epizyme News
11.8 Jazz Pharmaceuticals
11.8.1 Jazz Pharmaceuticals Company Details
11.8.2 Jazz Pharmaceuticals Follicular Lymphoma Drugs Product Offered
11.8.3 Jazz Pharmaceuticals Follicular Lymphoma Drugs Market Size (2022 VS 2027)
11.8.4 Jazz Pharmaceuticals Main Business Overview
11.8.5 Jazz Pharmaceuticals News
12 Research Findings and Conclusion
Table 1. Follicular Lymphoma Drugs Market Size CAGR by Region (2022-2028) ($ Millions)
Table 2. Major Players of Chemotherapy Drug
Table 3. Major Players of Monoclonal Antibody
Table 4. Major Players of Kinase Inhibitor
Table 5. Major Players of CAR T-cell Therapy
Table 6. Major Players of Others
Table 7. Global Follicular Lymphoma Drugs Market Size by Type (2022-2028) ($ Millions)
Table 8. Global Follicular Lymphoma Drugs Market Size Market Share by Type (2022-2028)
Table 9. Global Follicular Lymphoma Drugs Market Size by Application (2022-2028) ($ Millions)
Table 10. Global Follicular Lymphoma Drugs Market Size Market Share by Application (2022-2028)
Table 11. Date of Global Key Players Enter into Follicular Lymphoma Drugs Market
Table 12. Global Key Players Follicular Lymphoma Drugs Product Offered
Table 13. Key Players Follicular Lymphoma Drugs Funding/Investment ($ Millions)
Table 14. Funding/Investment by Regions
Table 15. Funding/Investment by End Industry
Table 16. Key Players Follicular Lymphoma Drugs Valuation & Market Capitalization ($ Millions)
Table 17. Key Players Mergers & Acquisitions, Expansion Plans
Table 18. Follicular Lymphoma Drugs New Product/Technology Launches
Table 19. Follicular Lymphoma Drugs Industry Partnerships, Agreements, and Collaborations
Table 20. Follicular Lymphoma Drugs Industry Mergers and Acquisitions
Table 21. Global Follicular Lymphoma Drugs Market Size by Regions 2022-2028 ($ Millions)
Table 22. Global Follicular Lymphoma Drugs Market Size Market Share by Regions 2022-2028
Table 23. United States Follicular Lymphoma Drugs Market Size by Type (2022-2028) ($ Millions)
Table 24. United States Follicular Lymphoma Drugs Market Size Market Share by Type (2022-2028)
Table 25. United States Follicular Lymphoma Drugs Market Size by Application (2022-2028) ($ Millions)
Table 26. United States Follicular Lymphoma Drugs Market Size Market Share by Application (2022-2028)
Table 27. China Follicular Lymphoma Drugs Market Size by Type (2022-2028) ($ Millions)
Table 28. China Follicular Lymphoma Drugs Market Size Market Share by Type (2022-2028)
Table 29. China Follicular Lymphoma Drugs Market Size by Application (2022-2028) ($ Millions)
Table 30. China Follicular Lymphoma Drugs Market Size Market Share by Application (2022-2028)
Table 31. Europe Follicular Lymphoma Drugs Market Size by Type (2022-2028) ($ Millions)
Table 32. Europe Follicular Lymphoma Drugs Market Size Market Share by Type (2022-2028)
Table 33. Europe Follicular Lymphoma Drugs Market Size by Application (2022-2028) ($ Millions)
Table 34. Europe Follicular Lymphoma Drugs Market Size Market Share by Application (2022-2028)
Table 35. Rest of World Follicular Lymphoma Drugs Market Size by Type (2022-2028) ($ Millions)
Table 36. Rest of World Follicular Lymphoma Drugs Market Size Market Share by Type (2022-2028)
Table 37. Rest of World Follicular Lymphoma Drugs Market Size by Application (2022-2028) ($ Millions)
Table 38. Rest of World Follicular Lymphoma Drugs Market Size Market Share by Application (2022-2028)
Table 39. Key Market Drivers & Growth Opportunities of Follicular Lymphoma Drugs
Table 40. Key Market Challenges & Risks of Follicular Lymphoma Drugs
Table 41. Key Industry Trends of Follicular Lymphoma Drugs
Table 42. Company A Company Details
Table 43. Companies Invested by Company A
Table 44. Company A Key Development and Market Layout
Table 45. Company B Company Details
Table 46. Companies Invested by Company B
Table 47. Company B Key Development and Market Layout
Table 48. Company C Company Details
Table 49. Companies Invested by Company C
Table 50. Company C Key Development and Market Layout
Table 51. Company C Company Details
Table 52. Companies Invested by Company C
Table 53. Company C Key Development and Market Layout
Table 54. Genentech (Roche) Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. Genentech (Roche) Follicular Lymphoma Drugs Market Size (2022 VS 2027)
Table 56. Bristol-Myers Squibb Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Bristol-Myers Squibb Follicular Lymphoma Drugs Market Size (2022 VS 2027)
Table 58. Gilead Sciences Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. Gilead Sciences Follicular Lymphoma Drugs Market Size (2022 VS 2027)
Table 60. TG Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. TG Therapeutics Follicular Lymphoma Drugs Market Size (2022 VS 2027)
Table 62. Bayer Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. Bayer Follicular Lymphoma Drugs Market Size (2022 VS 2027)
Table 64. Secura Bio Basic Information, Head Office, Major Market Areas and Its Competitors
Table 65. Secura Bio Follicular Lymphoma Drugs Market Size (2022 VS 2027)
Table 66. Epizyme Basic Information, Head Office, Major Market Areas and Its Competitors
Table 67. Epizyme Follicular Lymphoma Drugs Market Size (2022 VS 2027)
Table 68. Jazz Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 69. Jazz Pharmaceuticals Follicular Lymphoma Drugs Market Size (2022 VS 2027)
List of Figures
Figure 1. Picture of Follicular Lymphoma Drugs
Figure 2. Follicular Lymphoma Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Follicular Lymphoma Drugs Market Size Growth Rate 2022-2028 ($ Millions)
Figure 7. Follicular Lymphoma Drugs Market Size by Region (2022 & 2027) ($ millions)
Figure 8. Global Follicular Lymphoma Drugs Market Size Market Share by Type (2022-2028)
Figure 9. Global Chemotherapy Drug Market Size Growth Rate
Figure 10. Global Monoclonal Antibody Market Size Growth Rate
Figure 11. Global Kinase Inhibitor Market Size Growth Rate
Figure 12. Global CAR T-cell Therapy Market Size Growth Rate
Figure 13. Global Others Market Size Growth Rate
Figure 14. Follicular Lymphoma Drugs in < 55
Figure 15. Global Follicular Lymphoma Drugs Market: < 55 (2022-2028) ($ Millions)
Figure 16. Follicular Lymphoma Drugs in 55-64
Figure 17. Global Follicular Lymphoma Drugs Market: 55-64 (2022-2028) ($ Millions)
Figure 18. Follicular Lymphoma Drugs in 65+
Figure 19. Global Follicular Lymphoma Drugs Market: 65+ (2022-2028) ($ Millions)
Figure 20. Global Follicular Lymphoma Drugs Market Size Market Share by Application (2022-2028)
Figure 21. Global Follicular Lymphoma Drugs Market Size in < 55 Growth Rate
Figure 22. Global Follicular Lymphoma Drugs Market Size in 55-64 Growth Rate
Figure 23. Global Follicular Lymphoma Drugs Market Size in 65+ Growth Rate
Figure 24. Funding/Investment
Figure 25. Global Follicular Lymphoma Drugs Market Size Market Share by Regions 2022-2028
Figure 26. United States Follicular Lymphoma Drugs Market Size 2022-2028 ($ Millions)
Figure 27. China Follicular Lymphoma Drugs Market Size 2022-2028 ($ Millions)
Figure 28. Europe Follicular Lymphoma Drugs Market Size 2022-2028 ($ Millions)
Figure 29. Rest of World Follicular Lymphoma Drugs Market Size 2022-2028 ($ Millions)
Figure 30. United States Follicular Lymphoma Drugs Consumption Market Share by Type in 2027
Figure 31. United States Follicular Lymphoma Drugs Market Size Market Share by Application in 2027
Figure 32. China Follicular Lymphoma Drugs Consumption Market Share by Type in 2027
Figure 33. China Follicular Lymphoma Drugs Market Size Market Share by Application in 2027
Figure 34. Europe Follicular Lymphoma Drugs Consumption Market Share by Type in 2027
Figure 35. Europe Follicular Lymphoma Drugs Market Size Market Share by Application in 2027
Figure 36. Rest of World Follicular Lymphoma Drugs Consumption Market Share by Type in 2027
Figure 37. Rest of World Follicular Lymphoma Drugs Market Size Market Share by Application in 2027
Similar Reports
The project logistics market in India is pegged at INR 200 bn in 2010 and is growing at a CAGR of 20%. Rapid core infrastructure development along with investment planned by the Government of India and private players will drive the project logistics market. The report begins with an introduction to the project logistics market in India, describing the types of cargo being transported and share...
- Publish Date: January 3, 2011
- $950
The luxury car market is expected to witness strong growth with rising number of foreign players planning expansions in the market. Growing number of young entrepreneurs in India inclined to drive luxury cars is brining about healthy demand for such cars. The report provides a brief overview of the automotive market in India, the production of passenger vehicles over years and the segmented share...
- Publish Date: January 5, 2011
- $950
In India, car accessories is a new concept which has gained popularity in recent times with growing usage of high end cars. The market can be divided into interior and exterior car accessories. In the Indian market, interior car accessories are more popular. The growing youth is providing a fillip to the market due to their perceptions and preferences. Although small cars are preferred by Indian c...
- Publish Date: January 28, 2011
- $950
